I have great pleasure in inviting you to join us in Cambridge for the 3rd International CNS GCT Symposium, following successful meetings in Kyoto in 2003 and Los Angeles in 2005. I look forward to welcoming you on behalf of the Children's Cancer and Leukaemia Group and the European Organising Committee. Together with other international leaders in the field of germ cell tumours from North America and Japan, we are creating an exciting programme which
should appeal to all those involved in the care of children and young people with intracranial germ cell tumours.